Prescription drugs in mexico have designed a world which is profitability.

In fact, prescription drugs in Mexico, including antiretroviral, are very inexpensive to manufacture. Their prices reflect what the market will bear, not what they cost to produce. U.S. pharmaceutical firms buy the basic ingredients to antiviral in bulk from other countries at incredibly inexpensive rates. This means that tabulating, packaging, marketing and transporting of the medicine, plus profit, adds 1285% to the basic price, already excessive. This ridiculous price cannot be justified except in terms of what the market will bear, as it bears no real relation to cost of production. To provide antiretroviral to the world, there would have to be a paradigm shift in our collective decision making processes. There are choices. All of them are in the arena of public policy, not medical research.

The aim of Mexican Pharmacy study was to describe the prescribing behavior of physicians in body. Mexican pharmacy keep focus was not on whether the drugs were indicated for the patient's illness, but on the layout and content of the prescription. In particular, Mexican pharmacy wished to study the quality of the prescriptions in terms of the adequacy and clarity of the information contained, and to describe the types, and number, of Mexican pharmacy prescribed by doctors.

Mexico